The table below shows Dare Bioscience, Inc.'s income statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
Line item
FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
Revenue
-
-
$2.81M
$10.00M
$0.00
-
Cost of revenue
$295.80K
$0.00
-
-
-
-
Gross profit
-
-
-
-
-
-
R&D
$5.52M
$14.31M
$21.54M
$30.04M
$30.62M
$20.77M
SG&A
$8.76M
DARE annual revenue (10-K history)
Dare Bioscience, Inc. reported annual revenue of $1.03M for fiscal year 2025. That is up 10429.4% from $9.78K in fiscal 2024. Over the 9 fiscal years shown, annual revenue grew from $625.00K (FY 2012) to $1.03M. Figures come from the company's audited annual reports as filed with the SEC.